Managing risk factors for atherosclerosis in critical limb ischaemia

European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery
Anders Gottsäter

Abstract

To review the best medical management of critical limb ischaemia (CLI). Published studies dealing with CLI and risk factors were searched for via PUBMED. Patients with critical limb ischaemia (CLI) have a one and ten year mortality of approximately 20% and 75% respectively. Risk factors for the development of peripheral atherosclerosis are the same as for coronary and cerebrovascular atherosclerosis namely diabetes mellitus, hyperlipidaemia, arterial hypertension, and smoking. As there are few studies of risk factor for peripheral arterial occlusive disease (PAOD), treatment recommendations are often based on studies in patients with coronary or cerebrovascular atherosclerosis. While waiting for specific studies, CLI patients should be treated according to current guidelines for other atherosclerotic patients.

References

Jan 25, 1990·The New England Journal of Medicine·L RosenbergS Shapiro
Jan 1, 1990·Anesthesiology·D T Mangano
Oct 1, 1988·European Journal of Vascular Surgery·F G Fowkes
Jun 1, 1982·The British Journal of Surgery·C R Quick, L T Cotton
Sep 28, 1995·The American Journal of Cardiology·W B Kannel
Aug 1, 1994·European Heart Journal·M P Heintzen, B E Strauer
Jul 28, 1993·JAMA : the Journal of the American Medical Association·M T VogtS B Hulley
May 1, 1996·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·I SmithJ T Powell
Mar 10, 2001·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·J BismuthH Sillesen
Jul 27, 2001·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·S W Cheng, A C Ting
Sep 19, 2001·JAMA : the Journal of the American Medical Association·A T HirschW R Hiatt
Nov 13, 2001·The American Journal of Cardiology·W S AronowI Kronzon
Sep 12, 2002·Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists·Hannes BalmerIris Baumgartner
Nov 19, 2002·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·B Jönsson, T Skau
Mar 5, 2004·ANZ Journal of Surgery·Ah Kian AhChongAndrew Wai Chun Yip
May 4, 2004·European Heart Journal·Martin SchillingerErich Minar
Aug 11, 2004·Journal of Consulting and Clinical Psychology·Antonio Cepeda-BenitoStephen Erath
Oct 9, 2004·Journal of Vascular Surgery·Jyrki VirkkunenUNKNOWN Finnvasc Study Group
Oct 21, 2004·JAMA : the Journal of the American Medical Association·Huyen Tran, Sonia S Anand
Dec 29, 2004·Journal of Vascular Surgery·Edith M WilligendaelMartin H Prins
Jul 14, 2005·Journal of Vascular Surgery·Jamal BaraniAnders Gottsäter

❮ Previous
Next ❯

Citations

Feb 3, 2016·Tissue Engineering. Part C, Methods·Dilip ThomasAbhay Pandit
Feb 4, 2010·Journal of Vascular and Interventional Radiology : JVIR·Joe J LeyonSuresh Babu
Jan 19, 2010·Clinical Biochemistry·Josefin AhnströmBjörn Dahlbäck
Jun 3, 2008·Journal of Vascular Surgery·Monica KuoppalaStefan Acosta
Jun 26, 2013·Journal of Internal Medicine·M A Lambert, J J F Belch
Jun 25, 2010·Journal of Vascular Surgery·James Ian SparkSonal Asthana
Feb 6, 2007·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·J SarveswaranJ I Spark

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.